Literature DB >> 11076117

The impact of managed care on substance abuse treatment: a report of the American Society of Addiction Medicine.

M Galanter, D S Keller, H Dermatis, S Egelko.   

Abstract

This report examines the impact of managed care (MC) and related developments on substance abuse treatment, and evaluates how it has been associated with a decline in the availability of proper treatment for many addicted patients. A trend toward carve-out and for-profit MC organizations is associated with lower financial incentives for intensive treatment than in earlier staff-model and not-for-profit MC organizations. The value of substance abuse insurance coverage has declined by 75% between 1988 and 1998 for employees of mid-to large-size companies, compared with only an 11.5% decline for general health insurance. The shift towards MC has also been associated with a drastic reduction in frequency and duration of inpatient hospitalization, and there is no clear evidence that this reduction has been offset by a corresponding increase in outpatient support. In a survey of physicians treating addiction, the majority felt that MC had a negative impact on detoxification and rehabilitation, and on their ethical practice of addiction medicine.

Entities:  

Mesh:

Year:  2000        PMID: 11076117     DOI: 10.1300/J069v19n03_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  17 in total

1.  Managed care and access to substance abuse treatment services.

Authors:  Jeffrey A Alexander; Tammie A Nahra; John R C Wheeler
Journal:  J Behav Health Serv Res       Date:  2003 Apr-Jun       Impact factor: 1.505

2.  Public managed care and service access in outpatient substance abuse treatment units.

Authors:  Emmeline Chuang; Rebecca Wells; Jeffrey A Alexander
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

3.  Access to drug abuse treatment under Treatment on Demand policy in San Francisco.

Authors:  James L Sorensen; Joseph Guydish; Pamela Zilavy; Thomas B Davis; Alice Gleghorn; Marvin Jacoby; Clare Sears
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

4.  Role of state policies in the adoption of naltrexone for substance abuse treatment.

Authors:  Carolyn J Heinrich; Carolyn J Hill
Journal:  Health Serv Res       Date:  2008-06       Impact factor: 3.402

5.  Development and Testing of an Addiction Treatment Level of Care Determination Tool.

Authors:  Megan A O'Grady; Charles J Neighbors; Patricia Lincourt; Constance Burke; Adrianna Maldonado
Journal:  J Behav Health Serv Res       Date:  2019-07       Impact factor: 1.505

6.  Organization and financing of alcohol and substance abuse programs for American Indians and Alaska Natives.

Authors:  Bentson H McFarland; Roy M Gabriel; Douglas A Bigelow; R Dale Walker
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

7.  Legislating clinical practice: counselor responses to an evidence-based practice mandate.

Authors:  Traci Rieckmann; Luke Bergmann; Caitlin Rasplica
Journal:  J Psychoactive Drugs       Date:  2011-09

8.  Opportunities in Reform: Bioethics and Mental Health Ethics.

Authors:  Arthur Robin Williams
Journal:  Bioethics       Date:  2015-09-30       Impact factor: 1.898

9.  Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.

Authors:  Andrew W Dick; Rosalie L Pacula; Adam J Gordon; Mark Sorbero; Rachel M Burns; Douglas Leslie; Bradley D Stein
Journal:  Health Aff (Millwood)       Date:  2015-06       Impact factor: 6.301

10.  Detrimental Effects of "Stretch" Goals in Specialty Substance Use Disorder Treatment Organizations.

Authors:  G James Lemoine; Terry C Blum; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2016-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.